Results 171 to 180 of about 4,318,091 (252)

GLP‐1 RA Plus SGLT2i Versus Monotherapy in MASLD and Type 2 Diabetes: Three Pairwise Target Trial Emulations

Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2862-2881, September 2026.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) have demonstrated cardiovascular and metabolic benefits individually; however, the comparative effectiveness of combination therapy versus monotherapy in patients with metabolic dysfunction‐associated steatotic liver ...
Mohanad A. Alkuwaiti, Faisal A. Al‐Harbi, Ahmed K. Alsaif, Ziyad M. AlSughayyir, Rayan Saleh Alsaud, Mohammed N. Aljabr, Ahmad K. Alanazi, Ahmad A. Alosaily, Abdulrhman K. Alabdulqader, Hamza Almusabeh, Rayyan F. Altemani, Ahmed Y. Azzam   +11 more
wiley   +1 more source

Cholecystectomy before diagnosis of primary sclerosing cholangitis is associated with markedly worsened transplant-free survival. [PDF]

JHEP Rep
Färkkilä MA, Arola JT, Tenca A, Jokelainen K, Boyd S, Kautiainen H.   +5 more
europepmc   +1 more source

Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective

Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2623-2638, September 2026.
ABSTRACT Primary biliary cholangitis (PBC) is an autoimmune liver disease that targets the small intrahepatic bile ducts with diagnosis based on elevated serum alkaline phosphatase (ALP) levels and the presence of anti‐mitochondrial antibodies. Untreated, it may run a progressive course to cirrhosis and hepatic decompensation, at which point liver ...
Simone I. Strasser, Alexander J. Thompson, Rohit Gupta, John Lubel, Janine French, Beverly Sacks, Martin Weltman   +6 more
wiley   +1 more source

Prognostic Significance of Cystic Biliary Dilatation in Primary Sclerosing Cholangitis. [PDF]

Turk J Gastroenterol
Parlar YE, Öztürk B, Keskin O, İsrafilov S, Kav T, Sökmensüer C, Doğrul AB, Parlak E.   +7 more
europepmc   +1 more source

The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia

Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2639-2655, September 2026.
ABSTRACT Background Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer‐related deaths in Malaysia. Early detection increases the likelihood of curative treatment and improves survival. This consensus document aims to provide evidence‐based, locally relevant recommendations for the prevention and early detection of HCC.
Su Yin Lau, Victoria Sinq‐Ling Kok, Soek‐Siam Tan, Syuhada Dan Adnan, Wei‐Lin Ng, Ban‐Hong Ang, Nur Yazmin Yaacob, Yeong Yeh Lee, Senamjit Kaur, Rosmawati Mohamed, Ping‐Foo Wong, Lee‐Ling Lim, Mohana Letchumanan, Shireene Ratna Vethakkan, Nurain Mohd Noor, Siow‐Foon Tan, Tiong‐Lim Low, Lee‐Boon Kiew, Wah‐Kheong Chan   +18 more
wiley   +1 more source

Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling. [PDF]

Nat Metab
Molinaro A, Braadland PR, Carpino G, Carreras A, Nikolaidis M, Hanzely P, Beck KR, Ali AH, Bossen L, Frank A, Lundqvist A, Juran BD, Overi D, Geng L, Amundsen-Isaksen E, Reims HM, Björk I, Grzyb K, Abildgaard A, Folseraas T, Cornillet M, Helgadóttir H, McCauley BM, Cristoferi L, Carbone M, Cardinale V, Høivik ML, Engesæter LK, Tjønnfjord SKV, McCann A, Ueland PM, Vesterhus M, Karlsen TH, Grønbæk H, Gaudio E, Lazaridis KN, Bergquist A, Melum E, Bäckhed F, Hov JR.   +39 more
europepmc   +1 more source

"From Cholestasis to Interface Hepatitis: A Rare Case of Primary Sclerosing Cholangitis-Autoimmune Hepatitis Overlap in a 20-Year-Old Male". [PDF]

Clin Med Insights Case Rep
Shah MH, Sethi AD, Osama M, Hasnain S, Shah R, Khan I, Khan A, Thada PK.   +7 more
europepmc   +1 more source

An Approach to Antibody‐Mediated Rejection in Pediatric Liver Transplantation

Pediatric Transplantation, Volume 30, Issue 9, September 2026.
ABSTRACT Antibody‐mediated rejection (AMR) is an important but infrequent cause of pediatric liver allograft injury. There is a lack of standardized guidance, and treatment approaches vary across institutions. A writing group from the Society of Pediatric Liver Transplantation conducted a comprehensive review of the published literature and collected ...
Catalina Jaramillo, Parmjeet Randhawa, Amrita Narang, Alison J. Gareau, Jody Weckwerth, Alisha Mavis, George Mazariegos, Katryn Furuya, Nanda Kerkar   +8 more
wiley   +1 more source

Cardiovascular risk profiles in patients with primary sclerosing cholangitis. [PDF]

Eur J Gastroenterol Hepatol
Sleutjes JAM, van de Pol N, van der Meer AJ, de Man RA, van der Woude CJ, Roeters van Lennep JE, de Vries AC.   +6 more
europepmc   +1 more source

Beyond the Graft: Optimizing Post-Transplant Care in Primary Sclerosing Cholangitis. [PDF]

J Clin Med
Becchetti C, Viganò R, Aprile F, Scaravaglio M, Vitale G, Perricone G, Mazzarelli C, Vangeli M, Belli LS, Carbone M, Morelli MC.   +10 more
europepmc   +1 more source